MONTREAL, Oct. 21, 2013 /CNW Telbec/ - Atrium Innovations Inc. (TSX: ATB) ("Atrium" or the "Company"), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, today announced that Mr. Alain Bouchard, a director of Atrium, has informed the Company of his decision to resign from the board, effective immediately.
"It is with regret that the board of directors of Atrium has accepted the resignation of Alain Bouchard. Mr. Bouchard has been a valuable member of our board since 2002 and throughout the years has provided valuable insight as the Company experienced its various stages of development. Alain is a remarkable entrepreneur and we are fortunate to have been able to benefit from his wisdom during the last decade" said Mr. Pierre Laurin, Ph.D., O.C., Chairman of the Board of Directors of Atrium.
About Atrium Innovations
Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries. The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,100 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available at www.atrium-innovations.com.
SOURCE: Atrium Innovations Inc.
Investor Relations:
Mario Paradis
Vice President and Chief Financial Officer
Tel.: 418 652-1116
[email protected]
Pierre Boucher
MaisonBrison Communications
Tel.: 514 731-0000, ext. 237
[email protected]
Media Relations:
Amélie Germain
Director of Communications
Tel.: 418 652-1116
[email protected]
Share this article